Pfizer meningitis vaccine wins FDA approval

October 30, 2014 11:22 AM

6 0

Pfizer meningitis vaccine wins FDA approval

Pfizer Inc has won U.S. approval for its Trumenba vaccine against meningitis B, a potentially deadly bacterial disease that has recently caused outbreaks on college campuses, the U.S. Food and Drug Administration said on Wednesday.

Trumenba, approved in individuals 10 to 25 years of age, has been considered one of the most important products in Pfizer's drug pipeline. It was granted accelerated approval following tests in 2,800 adolescents in the United States and Europe.

Also read: China to boost non-fossil fuel use to 20 percent by 2030: state planner

Read more

To category page